Literature DB >> 21388681

The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.

Francois P Duhoux, Nathalie Auger, Sigrid De Wilde, Sebastian Wittnebel, Geneviève Ameye, Khadija Bahloula, Catherine Van den Berg, Jeanne-Marie Libouton, Pascale Saussoy, Francis H Grand, Jean-Baptiste Demoulin, Hélène A Poirel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21388681     DOI： 10.1016/j.leukres.2011.02.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  16 in total

1.  Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia.

Authors:  Miriam Frech; Lutz B Jehn; Kathleen Stabla; Stephan Mielke; Björn Steffen; Hermann Einsele; Stephan K Metzelder; Andreas Neubauer
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

2.  Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.

Authors:  Thomas Perwein; Sabine Strehl; Margit König; Herwig Lackner; Renate Panzer-Grümayer; Georg Mann; Andishe Attarbaschi; Ernst-Christian Urban; Oskar A Haas
Journal:  Haematologica       Date:  2016-04-28       Impact factor: 9.941

3.  High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

Authors:  Kathryn G Roberts; Zhaohui Gu; Debbie Payne-Turner; Kelly McCastlain; Richard C Harvey; I-Ming Chen; Deqing Pei; Ilaria Iacobucci; Marcus Valentine; Stanley B Pounds; Lei Shi; Yongjin Li; Jinghui Zhang; Cheng Cheng; Alessandro Rambaldi; Manuela Tosi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Peter H Wiernik; Ravi Bhatia; Ibrahim Aldoss; Jessica Kohlschmidt; Krzysztof Mrózek; Guido Marcucci; Clara D Bloomfield; Wendy Stock; Stephen Kornblau; Hagop M Kantarjian; Marina Konopleva; Elisabeth Paietta; Cheryl L Willman; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

Review 4.  Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

Authors:  Tobias Herold; Nicola Gökbuget
Journal:  Curr Oncol Rep       Date:  2017-05       Impact factor: 5.075

Review 5.  Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.

Authors:  Nidhi Jyotsana; Michael Heuser
Journal:  Expert Opin Ther Targets       Date:  2017-12-20       Impact factor: 6.902

Review 6.  Philadelphia chromosome-like acute lymphoblastic leukemia.

Authors:  Sarah K Tasian; Mignon L Loh; Stephen P Hunger
Journal:  Blood       Date:  2017-10-02       Impact factor: 22.113

Review 7.  PSF: nuclear busy-body or nuclear facilitator?

Authors:  Christopher A Yarosh; Joseph R Iacona; Carol S Lutz; Kristen W Lynch
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-04-01       Impact factor: 9.957

Review 8.  RNA splicing factors as oncoproteins and tumour suppressors.

Authors:  Heidi Dvinge; Eunhee Kim; Omar Abdel-Wahab; Robert K Bradley
Journal:  Nat Rev Cancer       Date:  2016-06-10       Impact factor: 60.716

9.  TRAP150 interacts with the RNA-binding domain of PSF and antagonizes splicing of numerous PSF-target genes in T cells.

Authors:  Christopher A Yarosh; Iulia Tapescu; Matthew G Thompson; Jinsong Qiu; Michael J Mallory; Xiang-Dong Fu; Kristen W Lynch
Journal:  Nucleic Acids Res       Date:  2015-08-10       Impact factor: 16.971

10.  RCSD1-ABL1 Translocation Associated with IKZF1 Gene Deletion in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Shawana Kamran; Gordana Raca; Kamran Nazir
Journal:  Case Rep Hematol       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.